Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma

Analysis of single-cell RNA sequencing (scRNA-seq) data of immune cells from the tumor microenvironment (TME) may identify tumor progression biomarkers. This study was designed to investigate the prognostic value of differentially expressed genes (DEGs) in intrahepatic cholangiocarcinoma (ICC) using...

Full description

Bibliographic Details
Main Authors: Miao Su, Kuang-Yuan Qiao, Xiao-Li Xie, Xin-Ying Zhu, Fu-Lai Gao, Chang-Juan Li, Dong-Qiang Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2020.615680/full
_version_ 1819295899410497536
author Miao Su
Miao Su
Kuang-Yuan Qiao
Xiao-Li Xie
Xin-Ying Zhu
Xin-Ying Zhu
Fu-Lai Gao
Chang-Juan Li
Dong-Qiang Zhao
author_facet Miao Su
Miao Su
Kuang-Yuan Qiao
Xiao-Li Xie
Xin-Ying Zhu
Xin-Ying Zhu
Fu-Lai Gao
Chang-Juan Li
Dong-Qiang Zhao
author_sort Miao Su
collection DOAJ
description Analysis of single-cell RNA sequencing (scRNA-seq) data of immune cells from the tumor microenvironment (TME) may identify tumor progression biomarkers. This study was designed to investigate the prognostic value of differentially expressed genes (DEGs) in intrahepatic cholangiocarcinoma (ICC) using scRNA-seq. We downloaded the scRNA-seq data of 33,991 cell samples, including 17,090 ICC cell samples and 16,901 ICC adjacent tissue cell samples regarded as normal cells. scRNA-seq data were processed and classified into 20 clusters. The immune cell clusters were extracted and processed again in the same way, and each type of immune cells was divided into several subclusters. In total, 337 marker genes of macrophages and 427 marker genes of B cells were identified by comparing ICC subclusters with normal subclusters. Finally, 659 DEGs were obtained by merging B cell and macrophage marker genes. ICC sample clinical information and gene expression data were downloaded. A nine-prognosis-related-gene (PRG) signature was established by analyzing the correlation between DEGs and overall survival in ICC. The robustness and validity of the signature were verified. Functional enrichment analysis revealed that the nine PRGs were mainly involved in tumor immune mechanisms. In conclusion, we established a PRG signature based on scRNA-seq data from immune cells of patients with ICC. This PRG signature not only reflects the TME immune status but also provides new biomarkers for ICC prognosis.
first_indexed 2024-12-24T04:49:33Z
format Article
id doaj.art-315b887a7da64f63b05f7db9a1de2567
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-24T04:49:33Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-315b887a7da64f63b05f7db9a1de25672022-12-21T17:14:35ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-02-011110.3389/fgene.2020.615680615680Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic CholangiocarcinomaMiao Su0Miao Su1Kuang-Yuan Qiao2Xiao-Li Xie3Xin-Ying Zhu4Xin-Ying Zhu5Fu-Lai Gao6Chang-Juan Li7Dong-Qiang Zhao8Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, Hengshui People's Hospital, Hengshui, ChinaBasic Medical College, Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Third Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaAnalysis of single-cell RNA sequencing (scRNA-seq) data of immune cells from the tumor microenvironment (TME) may identify tumor progression biomarkers. This study was designed to investigate the prognostic value of differentially expressed genes (DEGs) in intrahepatic cholangiocarcinoma (ICC) using scRNA-seq. We downloaded the scRNA-seq data of 33,991 cell samples, including 17,090 ICC cell samples and 16,901 ICC adjacent tissue cell samples regarded as normal cells. scRNA-seq data were processed and classified into 20 clusters. The immune cell clusters were extracted and processed again in the same way, and each type of immune cells was divided into several subclusters. In total, 337 marker genes of macrophages and 427 marker genes of B cells were identified by comparing ICC subclusters with normal subclusters. Finally, 659 DEGs were obtained by merging B cell and macrophage marker genes. ICC sample clinical information and gene expression data were downloaded. A nine-prognosis-related-gene (PRG) signature was established by analyzing the correlation between DEGs and overall survival in ICC. The robustness and validity of the signature were verified. Functional enrichment analysis revealed that the nine PRGs were mainly involved in tumor immune mechanisms. In conclusion, we established a PRG signature based on scRNA-seq data from immune cells of patients with ICC. This PRG signature not only reflects the TME immune status but also provides new biomarkers for ICC prognosis.https://www.frontiersin.org/articles/10.3389/fgene.2020.615680/fullintrahepatic cholangiocarcinomasingle-cell RNA sequencingimmune cellsdifferentially expressed genesprogression
spellingShingle Miao Su
Miao Su
Kuang-Yuan Qiao
Xiao-Li Xie
Xin-Ying Zhu
Xin-Ying Zhu
Fu-Lai Gao
Chang-Juan Li
Dong-Qiang Zhao
Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
Frontiers in Genetics
intrahepatic cholangiocarcinoma
single-cell RNA sequencing
immune cells
differentially expressed genes
progression
title Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
title_full Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
title_fullStr Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
title_full_unstemmed Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
title_short Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
title_sort development of a prognostic signature based on single cell rna sequencing data of immune cells in intrahepatic cholangiocarcinoma
topic intrahepatic cholangiocarcinoma
single-cell RNA sequencing
immune cells
differentially expressed genes
progression
url https://www.frontiersin.org/articles/10.3389/fgene.2020.615680/full
work_keys_str_mv AT miaosu developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT miaosu developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT kuangyuanqiao developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT xiaolixie developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT xinyingzhu developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT xinyingzhu developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT fulaigao developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT changjuanli developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma
AT dongqiangzhao developmentofaprognosticsignaturebasedonsinglecellrnasequencingdataofimmunecellsinintrahepaticcholangiocarcinoma